18F-FDOPA PET/CT Imaging in Patients Undergoing Metabolic Surgery

NCT03821961 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2020-02-26

No results posted yet for this study

Summary

The aim of the study is to compare the endocrine function of pancreas between pre and post metabolic surgery in patients with type 2 diabetes or prediabetes. The study will examine the endocrine function of pancreas using 18F-FDOPA PET/CT imaging and various biochemical laboratory tests

Conditions

Interventions

PROCEDURE

Metabolic Surgery

Roux-en-Y gastric bypass, Sleeve gastrectomy

Sponsors & Collaborators

  • Myungmoon Pharma. Co. Ltd.

    collaborator INDUSTRY
  • Korea University Anam Hospital

    lead OTHER

Principal Investigators

  • Sungsoo Park, MD, PhD · Korea University Anam Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-03
Primary Completion
2020-11-30
Completion
2020-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03821961 on ClinicalTrials.gov